Gene therapy of neurodegenerative diseases: achievements, developments, and clinical implementation challenges
Neurodegenerative diseases (NDDs) are promising objects for the development of gene therapy products, primarily, due to the possible cause of these diseases (disruption of a gene or several genes), lack of effective therapy, and negative impact on the quality of life of both patients and their famil...
Saved in:
| Main Authors: | E. V. Melnikova, V. A. Merkulov, O. V. Merkulova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-06-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01) -
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury
by: Almir Aljović, et al.
Published: (2023-01-01) -
Brazilian version of the CHOP INTEND scale: cross-cultural adaptation and validation
by: Renalli Manuella Rodrigues Alves, et al.
Published: (2023-09-01) -
Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander): evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool Atrofia muscular espinhal tipo II (intermediária) e III (Kugelberg-Welander): evolução de 50 pacientes com fisioterapia e hidroterapia em piscina
by: Márcia C. B. Cunha, et al.
Published: (1996-09-01) -
An adeno-associated virus gene therapy strategy for anti-obesity treatment by nanocarrier-based delivery systems
by: Li Li, et al.
Published: (2025-07-01)